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Purpose: The ethanol extracts obtained from the leaves, rootstock and the combined formulation of 
endemic Salvia tigrina Hedge & Hub.-Mor. (Labiatea) have been investigated for their antifungal 
activities. 
Method: The antifungal activity of the extract was tested against Candida species (C. albicans ATCC 
10231, C. tropicalis ATCC 13803 and C. guilliermondii ATCC 6260 and Cryptococcus species (C. 
neoformans ATCC 90112 and C. laurentii 34142), Aspergillus flavus, Penicillium frequentans, Botrytis 
cinerea, Geotrichum candidum, Fusarium oxysporum and Alternaria alternara by the visual broth 
macrodilution method. Ketoconazole was used as a positive reference standard to determine the 
sensitivity of the strains. 
Results: The minimum inhibitory concentration (MIC) ranged from 3.12 to 25 mg/mL. All the extracts 
exhibited a strong antifungal effect against the fungal cultures. The extracts exhibited greater antifungal 
effect against C. albicans, C. neoformans and B. cinarea.  
Conclusion: The findings provide support for the use of this plant in traditional medicine for fungal 
infections especially against candidiasis.  
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INTRODUCTION 
Turkey is regarded as an important gene-
centre for the Labiatae family which is 
represented in Turkey by 45 genera, 546 
species and a total of 731 taxa. The rate of 
endemism in the family is 44.2%. Salvia 
(Labiatae) is repesented in Turkey by 94 taxa 
belonging to 89 species with 50% endemism. 




Several species of Salvia are used in folk 
medicine as antiseptics, astringents and 
spasmolytics
2
. Many studies have shown the 
antioxidant, antimicrobial and antiviral 
activities of some Salvia species
3-6
. S. 
officinalis and S. fruticosa are used as 
flavouring agents in perfumary
7
. The essential 
oil of S. sclarea shows significant 




Although there have been many investigations 
on Salvia species, Salvia tigrina has not been 
previously studied, to the best of our 
knowledge. During our routine field exursion in 
Turkey, it was found that this plant is used to 
treat cold, bronchitis, urinary tract infections 
and, externally, boils, abscesses. Thus, the 
purpose of this study is to investigate the 
antifungal activity of selected organic solvents 
extracts of this plant against some pathogenic 
fungi. 
 
MATERIALS AND METHODS 
 
Plant material 
The plant material was collected from Icel, 
Turkey in September, 2007. Voucher 
specimens of the plant were deposited in the 
Biology Department at Canakkale Onsekiz 
Mart University and identified by Ersin 
Karabacak from the same Department.  
Preparation of extracts 
The plant parts (leaf and rootstock) were air-
dried. The dry powdered plant material (20 g), 
either of the leaf or the roortstock, was soaked 
in the %50 ethanol until complete saturation of 
the plant material. The extract was filtered 
using Whatman filter paper no. 1, and the 
filtrate solvent was evaporated under vacuum 
using a rotary evaporator at 55°C. The 
resulting dried extract was stored in labeled 
sterile screw-capped bottles at -20°C. The 
extract (in the form of sticky black substances) 
amounting to around 2 g was dissolved in 0.1 
mL of DMSO (5 mg/g) (dimethyl sulfoxide) 
before testing. The combination of plant 
extracts, leaf and rootstock, (1:1 ratio) was 
also used in this test
9
. Candida species (C. 
albicans ATCC 10231, C. tropicalis ATCC 
13803 and C. guilliermondii ATCC 6260) and 
Cryptococcus species (C. neoformans ATCC 
90112 and C. laurentii 34142), Aspergillus 
flavus, Penicillium frequentans, Botrytis 
cinerea, Geotrichum candidum, Fusarium 
oxysporum and Alternaria alternara which 
were used as the test fungi were obtained 
from the Microbiology Research Laboratory in 
Canakkale Onsekiz Mart University, 
Department of Biology, Turkey and pure 
cultures were maintained on Sabouraud 
Dextrose Agar (SDA) plates and Sabouraud 
Dextrose Broth (SDB) in tubes.  
 
Minimum inhibitory concentration (MIC) 
determination 
MICs were performed by the visual broth 
macrodilution method
10
. Fungal suspensions 
were diluted added to RPMI-1640 medium 
without bicarbonate (buffered to pH 7.0 with 
0.165 M morpholinepropanesulfonic acid) 
broth supplemented with glutamine, to a 
concentration of approximately 0.5 x 10
5
 
CFU/mL (verified by colony counts in SDA). A 
twofold serial dilution of 0.2 mL each of extract 
was added to 1.8 mL of the RPMI-1640 
medium. The concentrations were in the 
range, 0.390–200 mg/mL. Controls used were 
medium without antifungal agents were used 
in the test. The results for the extracts were 
compared with a standard, ketoconazole. The 
tubes were then incubated at 35°C for 24 - 
48h. MIC was defined as the lowest 
concentration that did not yield visual growth. 
All experiments were performed in triplicate.  
 
RESULT  
The MICs values of the extracts are presented 
in Table 1. The MIC results for the ethanol 
extract of the leaf, rootstock and the 
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combination of both, ranged from 6.25 - 25, 
12.5 - 25 and 3.12-12.5 mg/mL, respectively, 
and showed that activity of the extracts varied 
from one fungal strain to another. The extract 
combination (both leaf and rootstock) 
exhibited stronger antifungal activity than the 
individual extract. Candida albicans, 
Cryptococcus neoformans and Botrytis 
cinarea with MIC of 3.12 mg/mL were more 
susceptible to the extract combination than 
other fungi, followed by Candida guilliermondii 
and Geotrichum candidum with MIC of 6.25 
mg/mL.  The MIC for the other fungi was 12.5 
mg/mL. However, the extracts and extract 
combinations  were less active than the 
standard antifungal agent, ketoconazole. 
 
DISCUSSION 
Fungi used in this study were chosen primarily 
on the basis of their importance as pathogens 
of humans and plants. Botrytis cinerea is a 
fungus that affects many plant species, 
although its most notable hosts may be wine 
grapes. In viticulture, it is commonly known as 
botrytis bunch rot; in horticulture, it is usually 
called grey mould or gray mold. According to 
findings from the National Nosocomial 
Infection Surveillance System (NNIS), 61% of 
reported nosocomial fungal infections were 
due to Candida albicans, followed by other 
Candida spp. and Cryptococcus spp.
11
. 
Candida albicans, while naturally occurring in 
the intestinal flora, can cause oral thrush and 
systemic infections. Cryptococcus neoformans 
causes cryptococcosis, an opportunistic 
infection of the lungs especially in AIDS 
patients.  
Ethanol was found to the best solvent for 
extracting antimicrobial substances in a 
previous study 
12
. The results in this study with 
ethanol are similar to those reported in the 
mentioned study. It is important to note that 
the concentration of extract used in the test 
may be correlated with a high activity of its 
chemical components.  
The major components of Salvia species 
growing in Turkey are α-pinene, β-pinene, β-
thujone, camphor, carvacrol, lynalyl acetate, 
sabinyl acetate and 1,8-cineole
13
. However, 
the composition of the essential oil of S. 
tigrina has not been reported. The mentioned 
substances may be responsible for the 
antifungal activity in S. tigrina. The antifungal 
activities of the essential oils of Salvia 
Table 1: Minimum inhibitory concentration of the ethanol leaf and rootstock 
 










Candida albicans 6.25 12.5 3.12 0.25 
Candida tropicalis 25 12.5 3.12 4 
Candida guilliermondii 25 25 12.5 5 
Cryptococcus neoformans 12.5 25 3.12 0.25 
Cryptococcus laurentii 25 25 12.5 4 
Aspergillus flavus 25 25 12.5 0.25 
Geotrichum candidum 25 12.5 6.25 0.25 
Fusarium oxysporum 25 25 12.5 0.12 
Penicillium frequentans 25 25 12.5 2 
Botrytis cinerea 12.5 6.25 3.12 0.25 
Alternaria alternata 25 25 12.5 0.5 
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lavandulifolia, S. officinalis and S. sclarea 
against various Candida species were 
reported to be high
14
. In another study, the 
essential oil of S. multicaulis, S. kronenburgii 
and S. verticillata were tested against Candida 
albicans and some bacteria and were foud to 
be very effective especially against Candida 
albicans
15
. The essential oil of S. lachnocalyx 
were investigated for antimicrobial activity 
against fungal cultures. The bioassays 
showed significant inhibition against fungi with 
minimum inhibitory concentration in range of 
5-10 mg/mL
16
. The result of antifungal effects 
obtained in this study are similar to those  
reported in the above studies.  
 
CONCLUSION 
The results obtained in this work are in 
agreement with recent studies regarding 
antimicrobial activities of members of the 
Labiatae family. Salvia tigrina could be of 
importance in the search of new natural 
sources of bioactive compounds. 
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